A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight

NCT07738614 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

56

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity
Overweight

Interventions

DRUG: Eloralintide
DRUG: Placebo
DRUG: Acetaminophen

Sponsor

Eli Lilly and Company